Champions Oncology Inc (OTCMKTS:CSBR) President Ronnie Morris bought 29,695 shares of Champions Oncology stock in a transaction on Thursday, October 13th. The stock was acquired at an average price of $1.67 per share, for a total transaction of $49,590.65. Following the transaction, the president now directly owns 1,041,347 shares of the company’s stock, valued at $1,739,049.49. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Ronnie Morris also recently made the following trade(s):
- On Friday, October 14th, Ronnie Morris bought 10,305 shares of Champions Oncology stock. The stock was acquired at an average price of $1.66 per share, for a total transaction of $17,106.30.
- On Monday, October 10th, Ronnie Morris acquired 9,537 shares of Champions Oncology stock. The stock was purchased at an average price of $1.66 per share, for a total transaction of $15,831.42.
- On Tuesday, September 20th, Ronnie Morris acquired 3,000 shares of Champions Oncology stock. The stock was purchased at an average price of $1.58 per share, for a total transaction of $4,740.00.
Shares of Champions Oncology Inc (OTCMKTS:CSBR) opened at 1.68 on Tuesday. Champions Oncology Inc has a 12-month low of $1.11 and a 12-month high of $5.46. The company has a 50 day moving average price of $1.66 and a 200 day moving average price of $2.52. The stock’s market cap is $18.42 million.
Champions Oncology (OTCMKTS:CSBR) last released its quarterly earnings results on Friday, September 9th. The company reported ($0.15) earnings per share for the quarter. The company earned $3.70 million during the quarter.
About Champions Oncology
Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.
Receive News & Ratings for Champions Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology Inc and related companies with MarketBeat.com's FREE daily email newsletter.